Recomendaciones acerca de los aspectos éticos de los programas de cribado de población para enfermedades raras
Recommendations on ethical considerations in population screening programs for rare diseases
Comité de Ética del Instituto de Investigación de Enfermedades Raras*
Leído
11217
Vecesse ha leído el artículo
3150
Total PDF
8067
Total HTML
Información del artículo
ISSN: 02139111Idioma original: Español
Datos actualizados diariamente
| año/Mes | Html | Total | |
|---|---|---|---|
| 2025 6 | 216 | 189 | 405 |
| 2025 5 | 139 | 37 | 176 |
| 2025 4 | 127 | 44 | 171 |
| 2025 3 | 131 | 31 | 162 |
| 2025 2 | 136 | 37 | 173 |
| 2025 1 | 83 | 32 | 115 |
| 2024 12 | 73 | 30 | 103 |
| 2024 11 | 88 | 39 | 127 |
| 2024 10 | 89 | 47 | 136 |
| 2024 9 | 70 | 37 | 107 |
| 2024 8 | 88 | 41 | 129 |
| 2024 7 | 69 | 27 | 96 |
| 2024 6 | 71 | 46 | 117 |
| 2024 5 | 82 | 32 | 114 |
| 2024 4 | 81 | 33 | 114 |
| 2024 3 | 65 | 22 | 87 |
| 2024 2 | 76 | 53 | 129 |
| 2024 1 | 59 | 48 | 107 |
| 2023 12 | 57 | 21 | 78 |
| 2023 11 | 80 | 48 | 128 |
| 2023 10 | 51 | 37 | 88 |
| 2023 9 | 76 | 23 | 99 |
| 2023 8 | 50 | 18 | 68 |
| 2023 7 | 74 | 26 | 100 |
| 2023 6 | 65 | 24 | 89 |
| 2023 5 | 97 | 24 | 121 |
| 2023 4 | 82 | 31 | 113 |
| 2023 3 | 50 | 35 | 85 |
| 2023 2 | 63 | 34 | 97 |
| 2022 1 | 49 | 22 | 71 |
| 2022 12 | 61 | 20 | 81 |
| 2022 11 | 86 | 59 | 145 |
| 2022 10 | 78 | 41 | 119 |
| 2022 9 | 58 | 32 | 90 |
| 2022 8 | 61 | 75 | 136 |
| 2022 7 | 73 | 60 | 133 |
| 2022 6 | 55 | 44 | 99 |
| 2022 5 | 71 | 65 | 136 |
| 2022 4 | 63 | 52 | 115 |
| 2022 3 | 76 | 62 | 138 |
| 2022 2 | 66 | 49 | 115 |
| 2021 1 | 74 | 44 | 118 |
| 2021 12 | 64 | 48 | 112 |
| 2021 11 | 65 | 64 | 129 |
| 2021 10 | 70 | 71 | 141 |
| 2021 9 | 64 | 57 | 121 |
| 2021 8 | 60 | 43 | 103 |
| 2021 7 | 68 | 23 | 91 |
| 2021 6 | 82 | 38 | 120 |
| 2021 5 | 90 | 62 | 152 |
| 2021 4 | 210 | 135 | 345 |
| 2021 3 | 87 | 45 | 132 |
| 2021 2 | 62 | 39 | 101 |
| 2020 1 | 52 | 21 | 73 |
| 2020 12 | 69 | 31 | 100 |
| 2020 11 | 53 | 24 | 77 |
| 2020 10 | 40 | 27 | 67 |
| 2020 9 | 46 | 29 | 75 |
| 2020 8 | 42 | 31 | 73 |
| 2020 7 | 57 | 18 | 75 |
| 2020 6 | 48 | 33 | 81 |
| 2020 5 | 65 | 18 | 83 |
| 2020 4 | 83 | 23 | 106 |
| 2020 3 | 55 | 14 | 69 |
| 2020 2 | 71 | 26 | 97 |
| 2020 1 | 36 | 17 | 53 |
| 2019 12 | 42 | 35 | 77 |
| 2019 11 | 31 | 3 | 34 |
| 2019 10 | 43 | 22 | 65 |
| 2019 9 | 30 | 8 | 38 |
| 2019 8 | 31 | 9 | 40 |
| 2019 7 | 37 | 8 | 45 |
| 2019 6 | 33 | 29 | 62 |
| 2019 5 | 42 | 28 | 70 |
| 2019 4 | 146 | 12 | 158 |
| 2019 3 | 23 | 9 | 32 |
| 2019 2 | 30 | 26 | 56 |
| 2019 1 | 23 | 25 | 48 |
| 2018 12 | 11 | 4 | 15 |
| 2018 11 | 35 | 5 | 40 |
| 2018 10 | 41 | 24 | 65 |
| 2018 9 | 18 | 13 | 31 |
| 2018 8 | 28 | 23 | 51 |
| 2018 7 | 37 | 6 | 43 |
| 2018 6 | 37 | 7 | 44 |
| 2018 5 | 34 | 4 | 38 |
| 2018 4 | 26 | 6 | 32 |
| 2018 3 | 21 | 7 | 28 |
| 2018 2 | 16 | 7 | 23 |
| 2018 1 | 32 | 5 | 37 |
| 2017 12 | 28 | 8 | 36 |
| 2017 11 | 35 | 6 | 41 |
| 2017 10 | 28 | 10 | 38 |
| 2017 9 | 16 | 8 | 24 |
| 2017 8 | 13 | 4 | 17 |
| 2017 7 | 17 | 7 | 24 |
| 2017 6 | 25 | 4 | 29 |
| 2017 5 | 22 | 4 | 26 |
| 2017 4 | 36 | 6 | 42 |
| 2017 3 | 40 | 2 | 42 |
| 2017 2 | 21 | 3 | 24 |
| 2016 1 | 18 | 4 | 22 |
| 2016 12 | 31 | 2 | 33 |
| 2016 11 | 32 | 8 | 40 |
| 2016 10 | 31 | 7 | 38 |
| 2016 9 | 33 | 3 | 36 |
| 2016 8 | 46 | 10 | 56 |
| 2016 7 | 25 | 5 | 30 |
| 2015 7 | 1 | 0 | 1 |
| 2015 5 | 1 | 0 | 1 |
| 2015 2 | 2 | 0 | 2 |
| 2015 1 | 1 | 0 | 1 |
| 2014 12 | 1 | 0 | 1 |
| 2014 11 | 3 | 0 | 3 |
| 2014 10 | 3 | 0 | 3 |
| 2014 9 | 3 | 0 | 3 |
| 2014 8 | 5 | 0 | 5 |
| 2014 7 | 5 | 0 | 5 |
| 2014 6 | 6 | 0 | 6 |
| 2014 5 | 3 | 0 | 3 |
| 2014 4 | 2 | 1 | 3 |
| 2014 3 | 5 | 1 | 6 |
| 2014 2 | 4 | 2 | 6 |
| 2014 1 | 4 | 1 | 5 |
| 2013 12 | 7 | 0 | 7 |
| 2013 11 | 9 | 3 | 12 |
| 2013 10 | 12 | 2 | 14 |
| 2013 9 | 8 | 4 | 12 |
| 2013 8 | 18 | 1 | 19 |
| 2013 7 | 11 | 1 | 12 |
| 2006 12 | 1611 | 0 | 1611 |
Mostrar todo
